M.S. Kies

1.2k total citations
49 papers, 901 citations indexed

About

M.S. Kies is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Otorhinolaryngology. According to data from OpenAlex, M.S. Kies has authored 49 papers receiving a total of 901 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 22 papers in Otorhinolaryngology. Recurrent topics in M.S. Kies's work include Head and Neck Cancer Studies (22 papers), Lung Cancer Treatments and Mutations (17 papers) and Lung Cancer Research Studies (9 papers). M.S. Kies is often cited by papers focused on Head and Neck Cancer Studies (22 papers), Lung Cancer Treatments and Mutations (17 papers) and Lung Cancer Research Studies (9 papers). M.S. Kies collaborates with scholars based in United States, Netherlands and Malaysia. M.S. Kies's co-authors include George R. Blumenschein, Bonnie S. Glisson, Everett E. Vokes, Athanassios Argiris, Bharat B. Mittal, Daniel J. Haraf, Richard Pazdur, Robert B. Livingston, Saul E. Rivkin and John J. Crowley and has published in prestigious journals such as Journal of Clinical Oncology, Blood and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

M.S. Kies

47 papers receiving 870 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.S. Kies United States 16 591 341 296 281 191 49 901
Claudio Dansky Ullmann United States 14 398 0.7× 136 0.4× 219 0.7× 275 1.0× 139 0.7× 26 797
D.A. Clump United States 19 460 0.8× 413 1.2× 367 1.2× 193 0.7× 306 1.6× 47 1.1k
Hua-Qing Min China 9 314 0.5× 180 0.5× 436 1.5× 237 0.8× 323 1.7× 13 787
Sing-Fai Leung China 7 577 1.0× 224 0.7× 409 1.4× 218 0.8× 279 1.5× 12 1.1k
Martin Görner Germany 13 585 1.0× 215 0.6× 159 0.5× 117 0.4× 202 1.1× 23 939
Sandro Sulfaro Italy 16 518 0.9× 140 0.4× 476 1.6× 300 1.1× 505 2.6× 46 1.1k
Massimo Squadrelli Italy 10 351 0.6× 192 0.6× 698 2.4× 171 0.6× 523 2.7× 13 965
R Chin United States 12 314 0.5× 187 0.5× 147 0.5× 119 0.4× 180 0.9× 40 679
G. B. Snow Netherlands 12 338 0.6× 112 0.3× 302 1.0× 286 1.0× 195 1.0× 17 788
Gordon B. Snow Netherlands 6 426 0.7× 122 0.4× 627 2.1× 115 0.4× 396 2.1× 7 834

Countries citing papers authored by M.S. Kies

Since Specialization
Citations

This map shows the geographic impact of M.S. Kies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.S. Kies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.S. Kies more than expected).

Fields of papers citing papers by M.S. Kies

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.S. Kies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.S. Kies. The network helps show where M.S. Kies may publish in the future.

Co-authorship network of co-authors of M.S. Kies

This figure shows the co-authorship network connecting the top 25 collaborators of M.S. Kies. A scholar is included among the top collaborators of M.S. Kies based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.S. Kies. M.S. Kies is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Glisson, Bonnie S., Erminia Massarelli, William N. William, et al.. (2017). Nivolumab and ISA 101 HPV vaccine in incurable HPV-16+ cancer. Annals of Oncology. 28. v403–v404. 17 indexed citations
2.
Massarelli, Erminia, Heather Lin, Lawrence E. Ginsberg, et al.. (2015). Phase II trial of everolimus and erlotinib in patients with platinum-resistant recurrent and/or metastatic head and neck squamous cell carcinoma. Annals of Oncology. 26(7). 1476–1480. 69 indexed citations
3.
Argiris, Athanassios, Αthanasios Kotsakis, Tien Hoang, et al.. (2012). Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck. Annals of Oncology. 24(1). 220–225. 115 indexed citations
4.
Kim, E. S., M.S. Kies, Bonnie S. Glisson, et al.. (2007). Final results of a phase II study of erlotinib, docetaxel and cisplatin in patients with recurrent/metastatic head and neck cancer. Journal of Clinical Oncology. 25(18_suppl). 6013–6013. 36 indexed citations
5.
Zinner, Ralph, Frank V. Fossella, M.S. Kies, et al.. (2007). A phase II trial of pemetrexed (P) in patients (pts) with performance status (PS) 2 and 3 as first- and second-line treatment for advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 25(18_suppl). 18149–18149. 1 indexed citations
6.
Kies, M.S., Adam S. Garden, F. Christopher Holsinger, et al.. (2006). Induction chemotherapy (CT) with weekly paclitaxel, carboplatin, and cetuximab for squamous cell carcinoma of the head and neck (HN). Journal of Clinical Oncology. 24(18_suppl). 5520–5520. 28 indexed citations
7.
Horwitz, Eric M., Jonathan Harris, Corey J. Langer, et al.. (2005). Phase II Study of Paclitaxel and Cisplatin in Combination with Split Course Concomitant Hyperfractionated Re-Irradiation in Patients with Recurrent Squamous Cell Cancer of the Head and Neck: Results of RTOG 99-11. International Journal of Radiation Oncology*Biology*Physics. 63. S72–S73. 7 indexed citations
8.
9.
10.
Blumenschein, G. R., M.S. Kies, B.S. Glisson, et al.. (2004). Phase II clinical trial of suberoylanilide hydroxamic acid (SAHA) in patients (pts) with recurrent and/or metastatic head and neck cancer(SCCHN). Journal of Clinical Oncology. 22(14_suppl). 5578–5578. 9 indexed citations
11.
Rugo, H. S., Roy S. Herbst, Guoqiang Liu, et al.. (2004). Clinical and dynamic imaging results of the first phase I study of AG–013736, an oral anti-angiogenesis agent, in patients (pts) with advanced solid tumors. Journal of Clinical Oncology. 22(14_suppl). 2503–2503. 13 indexed citations
12.
Argiris, Athanassios, Stephanie M. Smith, Kerstin Stenson, et al.. (2003). Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary. Annals of Oncology. 14(8). 1306–1311. 39 indexed citations
13.
Oh, Julia, Everett E. Vokes, M.S. Kies, et al.. (2003). Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer. Annals of Oncology. 14(4). 564–569. 71 indexed citations
14.
15.
Haines, G. Kenneth, Stephen M. Becker, Ghanashyam D. Ghadge, et al.. (1993). Expression of the Double-Stranded RNA-Dependent Protein Kinase (p68) in Squamous Cell Carcinoma of the Head and Neck Region. Archives of Otolaryngology - Head and Neck Surgery. 119(10). 1142–1147. 24 indexed citations
16.
Haines, G. Kenneth, Ghanashyam D. Ghadge, Stephen M. Becker, et al.. (1993). Correlation of the expression of double-stranded RNA-dependent protein kinase (p68) with differentiation in head and neck squamous cell carcinoma. Virchows Archiv B Cell Pathology Including Molecular Pathology. 63(1). 289–295. 18 indexed citations
17.
18.
Gordon, Leo I., et al.. (1984). Estimation of hemopoietic potential by CFU-c and bone marrow scan in cancer patients.. PubMed. 12(2). 101–6. 1 indexed citations
19.
Maciorowski, Zofia, Leo I. Gordon, M.S. Kies, et al.. (1983). Estrogen receptor analysis in chronic lymphocytic leukemia. Blood. 62(5). 996–999. 33 indexed citations
20.
Kies, M.S., et al.. (1978). Radionuclide scans in staging of carcinoma of the lung.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 147(2). 175–6. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudio Dansky Ullmann Breakdown of academic impact, for papers by D.A. Clump Breakdown of academic impact, for papers by Hua-Qing Min Breakdown of academic impact, for papers by Sing-Fai Leung Breakdown of academic impact, for papers by Martin Görner Breakdown of academic impact, for papers by Sandro Sulfaro Breakdown of academic impact, for papers by Massimo Squadrelli Breakdown of academic impact, for papers by R Chin Breakdown of academic impact, for papers by G. B. Snow Breakdown of academic impact, for papers by Gordon B. Snow
Rankless by CCL
2026